Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2014/764581 http://scihub22266oqcxt.onion/10.1155/2014/764581 C4026877!4026877 !24895607     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24895607 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Res+Int 2014 ; 2014 (ä): 764581 Nephropedia Template TP {{tp|p=24895607 |t=2014. Application of proteomics and peptidomics to COPD |pdf=|usr=}}{{24895607 }} gab.com Text Application of proteomics and peptidomics to COPD JO: Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24895607 #FOAvip Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung parenchyma, usually associated with progressive and poorly reversible airflow limitation. In order to better characterize the phenotypic heterogeneity and the prognosis of patients with COPD, there is currently an urgent need for discovery and validation of reliable disease biomarkers. Within this context, proteomic and peptidomic techniques are emerging as very valuable tools that can be applied to both systemic and pulmonary samples, including peripheral blood, induced sputum, exhaled breath condensate, bronchoalveolar lavage fluid, and lung tissues. Identification of COPD biomarkers by means of proteomic and peptidomic approaches can thus also lead to discovery of new molecular targets potentially useful to improve and personalize the therapeutic management of this widespread respiratory disease. Twit Text FOAVip Application of proteomics and peptidomics to COPD ????Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24895607 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24895607 #FOAvip English Wikipedia <ref>{{Cite pmid|24895607 }}</ref> Application of proteomics and peptidomics to COPD #MMPMID24895607 Pelaia G ; Terracciano R ; Vatrella A ; Gallelli L ; Busceti MT ; Calabrese C ; Stellato C ; Savino R ; Maselli R Biomed Res Int 2014[]; 2014 (ä): 764581 PMID24895607 show ga Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung parenchyma, usually associated with progressive and poorly reversible airflow limitation. In order to better characterize the phenotypic heterogeneity and the prognosis of patients with COPD, there is currently an urgent need for discovery and validation of reliable disease biomarkers. Within this context, proteomic and peptidomic techniques are emerging as very valuable tools that can be applied to both systemic and pulmonary samples, including peripheral blood, induced sputum, exhaled breath condensate, bronchoalveolar lavage fluid, and lung tissues. Identification of COPD biomarkers by means of proteomic and peptidomic approaches can thus also lead to discovery of new molecular targets potentially useful to improve and personalize the therapeutic management of this widespread respiratory disease. |Bronchoalveolar Lavage [MESH] |Humans [MESH] |Peptides/*metabolism [MESH] |Proteomics/*methods [MESH] |Pulmonary Disease, Chronic Obstructive/blood/*metabolism/therapy [MESH] |Respiration [MESH]Application of proteomics and peptidomics to COPD (epmc).pdf DeepDyve Pubget Overpricing